Clinical findings in determining referral criteria for coronavirus disease (COVID-19) patients at a makeshift isolation center of Bekasi, West Java

Stefi Geovani Valentin Hayon(1*), Florentina Priscilia(2), Hariri -(3)

(1) General Practitioner, Makeshift COVID-19 Isolation Center of Bekasi District, Bekasi, Indonesia
(2) General Practitioner, Makeshift COVID-19 Isolation Center of Bekasi District, Bekasi, Indonesia
(3) Bekasi District Health Office, Bekasi, Indonesia
(*) Corresponding Author


COVID-19 has become a pandemic concern with the clinical manifestations ranging for asymptomatic to severe organ failure. Early contact tracing and isolation are important keys to slow the infection spread within communities. Clinical triage and early recognition of warning signs on admission are needed to classify patients based on clinical severity. Due to the limited capacity of hospital settings for COVID-19 patients, a makeshift isolation center is needed for all confirmed and suspected cases with mild or no symptoms who will be provided with basic medical care, frequent monitoring, and rapid referrals. During observations, the physician needs to raise early alertness of the patient who is at risk to develop a worse outcome. This study reports five cases of patients who came with mild or no symptoms at initial presentation and developed into worsening disease progression after several days of observation. These patients developed shortness of breath, fatigue, abdominal disturbances, and chest pain. These findings were supported by the physical examinations that showed a decrease in blood oxygen saturation. Similarly, with the Centers for Disease Control and Prevention (CDC) criteria for the early warning signs, these patients were referred to the hospital-based isolation setting that could provide more advanced and optimal management. This study describes clinical manifestations of COVID-19 patients to decide the ideal time for referral.


COVID-19; isolation center; referral criteria; early warning signs

Full Text:



  1. Huang R, Zhuid L, Xue L, Liu L, Yan X, Wang J, et al. Clinical findings of patients with coronavirus disease 2019 in Jiangsu Province, China: a retrospective, multi-center study. PLoS Negl Trop Dis [Internet]. 2020;14(5):1–14. Available from:
  2. Gao YM, Xu G, Wang B, Liu BC. Cytokine storm syndrome in coronavirus disease 2019: a narrative review. J Intern Med. 2020;(June):1–15.
  3. Ye Q, Wang B, Mao J. The pathogenesis and treatment of the “Cytokine Storm” in COVID-19. J Infect. 2020;80:607–13.
  4. World Health Organization. WHO coronavirus disease (COVID-19) dashboard [Internet]. 2021 [cited 2020 Sep 24]. Available from:
  5. Kemenkes RI. Infeki Emerging : Media Informasi Resmi Terkini Penyakit Infeksi Emerging [Internet]. 2020 [cited 2020 Sep 24]. Available from:
  6. Dickens BL, Koo JR, Wilder-Smith A, Cook AR. Institutional, not home-based, isolation could contain the COVID-19 outbreak. Lancet [Internet]. 2020;395(10236):1541–2. Available from:
  7. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet [Internet]. 2020;395(10223):507–13. Available from:
  8. Tenda ED, Yulianti M, Asaf MM, Yunus RE, Septiyanti W, Wulani V, et al. The importance of chest CT scan in COVID-19. Acta Med Indones. 2020;52(1):68–73.
  9. World Health Organization. Regional Office for the Western Pacific. (‎2020)‎. Algorithm for COVID-19 triage and referral: patient triage and referral for resource-limited settings during community transmission. Manila: WHO Regional Office for the Western Pacific.
  10. Karyono DR, Wicaksana AL. Current prevalence, characteristics, and comorbidities of patients with COVID-19 in Indonesia. J Community Empowerment Health. 2020;3(2):77–84.
  11. Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect. 2020;81(January).
  12. Hu B, Huang S, Yin L. The cytokine storm and COVID‐19. J Med Virol [Internet]. 2020;2:0–2. Available from:
  13. CDC. Symptoms of Coronavirus (COVID-19) [Internet]. Cdc. 2020 [cited 2020 Sep 24]. p. 317142. Available from:
  14. Tobin MJ, Laghi F, Jubran A. Why COVID-19 silent hypoxemia is baffling to physicians. Am J Respir Crit Care Med. 2020;202(3):356–60.
  15. Sun X, Wang T, Cai D, Hu Z, Chen J, Liao H, et al. Cytokine storm intervention in the early stages of COVID-19 pneumonia. Cytokine Growth Factor Rev [Internet]. 2020;53(April):38–42. Available from:


Article Metrics

Abstract views : 1150 | views : 1166


  • There are currently no refbacks.

Copyright (c) 2021 Journal of Community Empowerment for Health

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.